<DOC>
	<DOCNO>NCT02846519</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics intranasally administer esketamine healthy Han Chinese , Korean , Japanese , Caucasian participant evaluate effect rifampin pharmacokinetics intranasally administer esketamine healthy Caucasian participant .</brief_summary>
	<brief_title>Pharmacokinetic , Safety , Tolerability Study Intranasally Administered Esketamine Healthy Han Chinese , Korean , Japanese , Caucasian Participants Effects Rifampin Pharmacokinetics Intranasally Administered Esketamine</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<criteria>For Cohort 1 : healthy Han Chinese participant 20 55 year age , inclusive , reside outside China 10 year parent maternal paternal grandparent Han Chinese ethnicity For Cohort 2 : healthy Korean participant 20 55 year age , inclusive , reside outside Korea 10 year parent maternal paternal grandparent Korean ethnicity For Cohort 3 : healthy Japanese participant 20 55 year age , inclusive , reside outside Japan 10 year parent maternal paternal grandparent Japanese ethnicity For Cohort 4 : healthy Caucasian participant 20 55 year age , inclusive Participants must within +/7 year +/20 percent ( % ) combine mean age mean body weight Screening , respectively , Cohort 1 , Cohort 2 , Cohort 3 Body mass index ( BMI ; weight [ kilogram ] /height^2 [ ] ^2 ) 18 30 kilogram per meter square ( kg/m^2 ) , inclusive , body weight less 47 kilogram ( kg ) If woman , must negative serum betahuman chorionic gonadotropin ( betahCG ) pregnancy test Screening If woman , must agree donate egg ( ovum , oocytes ) purpose assist reproduction study 1 month receive last dose study drug Creatinine clearance equal ( &gt; = ) 80 milliliter per minute ( mL/min ) base CockroftGault equation Current significant psychiatric disorder include limited psychotic , bipolar , major depressive , anxiety disorder Clinically significant abnormal value hematology , clinical chemistry , urinalysis Screening Day 1 Period 1 deem appropriate investigator Clinically significant abnormal physical examination , vital sign , 12 lead electrocardiogram ( ECG ) Screening Day 1 Period 1 deem appropriate investigator History drug alcohol abuse disorder within past 1 year , reason believe participant history Regular use intranasal tobacco powder within past 1 year , reason believe participant history</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>